Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4024259019 | Brentuximab vedotin only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4024260012 | Product containing only brentuximab vedotin in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4864751000052116 | läkemedel som endast innehåller brentuximab vedotin, parenteral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Brentuximab vedotin only product in parenteral dose form | Is a | Brentuximab vedotin-containing product in parenteral dose form | true | Inferred relationship | Some | ||
| Brentuximab vedotin only product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Brentuximab vedotin only product in parenteral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Brentuximab vedotin only product in parenteral dose form | Is a | Brentuximab vedotin only product | true | Inferred relationship | Some | ||
| Brentuximab vedotin only product in parenteral dose form | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| Brentuximab vedotin only product in parenteral dose form | Has active ingredient | Brentuximab vedotin (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Is a | False | Brentuximab vedotin only product in parenteral dose form | Inferred relationship | Some | |
| Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | False | Brentuximab vedotin only product in parenteral dose form | Inferred relationship | Some | |
| Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial | Is a | True | Brentuximab vedotin only product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR